Sipra vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Sipra
Best for: compounded GLP-1 shoppers willing to prepay three months or more for one price at every dose
Visit Sipra →
Vytora Health
Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states
Visit Vytora Health →Sipra and Vytora Health are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Sipra starts lower at $149/mo versus $150/mo, and Vytora Health edges ahead overall (8.4 vs 7.1 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.
Pricing
Sipra
Shortest plan offered. 6-month plan $169/mo ($1,014 up front); 12-month plan $149/mo ($1,788 up front).
Shortest plan offered. 6-month plan $219/mo ($1,314 up front); 12-month plan $199/mo ($2,388 up front).
Low-dose program. 6-month plan $129/mo ($774 up front); 12-month plan $119/mo ($1,428 up front).
Low-dose program. 6-month plan $179/mo ($1,074 up front); 12-month plan $159/mo ($1,908 up front).
Daily tablet with B6. 6-month plan $219/mo ($1,314 up front); 12-month plan $199/mo ($2,388 up front).
Daily tablet. 6-month plan $249/mo ($1,494 up front); 12-month plan $239/mo ($2,868 up front).
Vytora Health
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 530+ providers' prices on their own sites and email you when tracked prices move.
What’s included
Sipra
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
Vytora Health
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Sipra
7.1/10
Vytora Health
8.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Sipra | Vytora Health |
|---|---|---|
| Starting Price | ✓$149/mo | $150/mo |
| Features | 8 features | 8 features |
| States Available | Not disclosed | 51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Sipra
Sipra is a telehealth platform that prescribes compounded semaglutide and tirzepatide as weekly injections, lower-dose microdose injections or dissolving tablets, with physicians from MDI Medical Group. There is no month-to-month option: the shortest plan is three months, paid up front once a physician approves, at $189/mo for semaglutide and $249/mo for tirzepatide. Longer plans cost less per month, the price does not rise with your dose, and shipping is free.
Read our full Sipra review →About Vytora Health
Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).
Read our full Vytora Health review →Pros & Cons
Sipra
What we like
- Every plan length, monthly rate and plan total is published on the pricing page before you answer a single question
- One price at every dose: the rate is set by plan length and does not rise as your physician steps the dose up
- Medication, physician review, dose changes, messaging and expedited shipping are in the plan price, with no membership fee
- Your card is charged only after a physician approves treatment; if treatment is declined, you owe nothing
- Six GLP-1 formats: semaglutide or tirzepatide as weekly injections, lower-dose microdose injections or dissolving tablets
- Names its prescribing group (MDI Medical Group) and its pharmacy partners in its terms
- Cancel online in your account, with no phone call or retention script
- HSA and FSA eligible; metformin, low-dose naltrexone, menopause hormone therapy and a lab panel are on the same account
Watch-outs
- No month-to-month option: the shortest plan is three months, charged as one up-front payment (for example, $567 for semaglutide)
- The headline "from $149/mo" is the 12-month rate; standard semaglutide costs $189/mo on the shortest plan
- Three-month plans are not refundable once a physician approves, even if nothing has shipped yet
- Leaving a 6- or 12-month plan early re-prices the months you keep at the higher shorter-plan rate before the rest is refunded
- Plans renew automatically at the rate posted at renewal; cancel at least 13 days before the period ends to stop the next order
- No phone support is published; help is by email, on-site chat and portal messaging
- A new brand: its current terms and refund policy took effect in October 2026, so there is little track record to judge
- Compounded semaglutide and tirzepatide are not FDA-approved
Vytora Health
What we like
- All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- Both compounded and brand-name options on one platform — uncommon
- LegitScript Approved and HIPAA compliant
- Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Watch-outs
- Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- Initial consultation cost not shown on the public pricing page
- Limited per-prescriber state licensure detail
Our Verdict
Vytora Health edges out Sipra with a higher overall score of 8.4/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Sipra remains a solid alternative, especially if you're looking for compounded GLP-1 shoppers willing to prepay three months or more for one price at every dose.
Choose Sipra if…
You want compounded GLP-1 shoppers willing to prepay three months or more for one price at every dose and a starting price around $149/mo.
Choose Vytora Health if…
You want compounded or brand-name GLP-1 with named pharmacy partners, 50 states and a starting price around $150/mo.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Wellorithm
Compounded GLP-1 access with oral tablet options across 49 states
From $147/mo
Get started →AgelessRx
Longevity-focused GLP-1 care
From $139/mo
Get started →Willow
Mainstream telehealth GLP-1 access
From $299/mo
Get started →Sipra vs Vytora Health: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Sipra and Vytora Health head-to-heads in the same category.
- Sipra vs Amazon One Medical
- Sipra vs Collective
- Sipra vs CoreAge Rx
- Vytora Health vs EverSlim
- Vytora Health vs Found
- Vytora Health vs NewSelf
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.